Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
IntroductionRituximab (RTX) is a monoclonal antibody targeting CD20, a transmembrane protein expressed on B cells, causing B cell depletion. RTX has shown great efficacy in studies of pemphigus vulgaris, but data of pemphigoid diseases are limited.ObjectiveTo assess the effectiveness and safety of R...
Main Authors: | Aniek Lamberts, H. Ilona Euverman, Jorrit B. Terra, Marcel F. Jonkman, Barbara Horváth |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2018.00248/full |
Similar Items
-
Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients
by: Gérôme Bohelay, et al.
Published: (2022-06-01) -
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease
by: Maria Efenesia Baffa, et al.
Published: (2022-07-01) -
Penfigoide bolhoso no lactente e seu principal diagnóstico diferencial: dermatose bolhosa por IgA linear
by: Luciana Silva de Godoy, et al.
Published: (2023-06-01) -
Diffuse blistering rash with ocular involvement
by: Shae Margulies, BS, et al.
Published: (2022-05-01) -
Case Report: The many faces of bullous pemphigoid
by: Laura Rechtien, et al.
Published: (2023-10-01)